Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Nektar Therapeutics (NASDAQ:NKTR) Doses First Patient In NKTR-255 Study In HNSCC…
BioCardia (NASDAQ:BCDA) Receives Positive Recommendation To Continue Piboatl CardiAMP™ Heart Failure…
Evofem Biosciences Inc. (NASDAQ:EVFM) Announces that Phase 3 EVO100 Trial Is…
Progenity Inc. (NASDAQ:PROG) Announces Expansion Of COVID-19 RT-PCR Test In The…
TG Therapeutics Inc. (NASDAQ:TGTX) Presents Triple Combination Data At 62nd American…
Finance
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
The Contrarian Opportunity in Sports Stocks (CHDN, DKNG, BTDG, DKS)
Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical…
OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply…
TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence…
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Home
Tags
Gilead Sciences Inc.
Tag: Gilead Sciences Inc.
Gilead Sciences Inc. (NASDAQ:GILD) Receives FDA Approval For Remdesivir In Treating...
Matt Wade
-
October 27, 2020
0
Gilead Sciences Inc. (NASDAQ:GILD) Announce $21 Billion Acquisition Of Cancer Drug...
Ward Sport
-
September 22, 2020
0
Gilead Sciences, Inc. (NASDAQ:GILD) Announces a Licensing Pact with Jounce Therapeutics...
Kate Hudson
-
September 9, 2020
0
.td-post-views{ display: none !important; }
